Kidney Outcomes with Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes and Moderate Cardiovascular Risk. uri icon

authors

  • Neumiller, Joshua J
  • McCoy, Rozalina G
  • Herrin, Jeph
  • Swarna, Kavya Sindhu
  • Polley, Eric C
  • Galindo, Rodolfo J
  • Umpierrez, Guillermo E
  • Deng, Yihong
  • Joseph S. Ross, MD, MHS
  • Mickelson, Mindy M

publication date

  • October 8, 2024